Pluvia Biotech

Private

BergenHealthcare & Life Scienceshttps://pluviabiotech.com/

Last Round

Seed

May 19, 2026

Total Funding Raised

$1.5M

Company Overview

Pluvia Biotech is a biotechnology company that develops oral pharmacological chaperones for the treatment of rare genetic disorders caused by protein misfolding, such as phenylketonuria (PKU).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

pharmacological chaperonesphenylketonuriaPKUrare disease drugorphan drugprotein misfoldingsmall-molecule drugbiotech spin-outdrug discoverypreclinical developmentmetabolic disordertherapeutic candidaterare disease biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluvia Biotech Comps

Public and private peers based on sector, stage, and business model.

Pluvia Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pluvia Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	May 19, 2026
Grant	Nov 25, 2025
Seed	Mar 1, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Torgeir Vaage

Chief Financial Officer

Executive Team

Pluvia Biotech Investors

Notable investors and investment history

Pluvia Biotech investors
Investor	Rounds
Investinor	Seed
Tidligfasekapital Vestland	Seed
Trond Mohn Research Foundation	Seed
Sarsia	Seed
MABA	Seed

View all Investors

Pluvia Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pluvia Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pluvia Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBergen

Employee Range10

Year Founded2015

Last FundingMay 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.